Abstract
Several evidences converge on the idea that among the mucosal administration routes, the nasal mucosa is the most attractive site for the delivery of vaccines. Mucoadhesive particulate adjuvants should be able to increase the residence time of antigens in nasal cavity in order to increase their probability of being taken up by nasopharynx-associated lymphoid tissue (NALT) cells and subsequently to initiate the innate and adaptive immune response. Focusing on chitosan, a mucoadhesive biopolymer, we describe in this chapter a method to prepare antigen loaded chitosan nanoparticles and a second method to prepare antigen loaded poly-ε-caprolactone/chitosan nanoparticles. Additionally the methodology for the assessment of mucoadhesivity of the delivery system is also described. The two critical procedures in mice intranasal immunization experiments include challenges in the intranasal administration itself due to the small mouse nose, and the other is related with the collection of mucosal secretions to assess the sIgA. The techniques are difficult to perform without advanced training. Therefore, protocols followed in our laboratory, as well as some tips, are described in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nat Med 11:S45–S53
Vasiliev YM (2015) Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation. Expert Rev Vaccines 14:37–53
Bento D, Staats HF, Goncalves T, Borges O (2015) Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. Eur J Pharm Biopharm 93:149–164
Chawla JS, Amiji MM (2002) Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 249:127–138
Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nanotoday 3:40–47
Mantle M, Allen A (1978) A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain [proceedings]. Biochem Soc Trans 6:607–609
Pawar D, Mangal S, Goswami R, Jaganathan KS (2013) Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur J Pharm Biopharm 85(3 Pt A):550–559
Dhawan S, Singla AK, Sinha VR (2004) Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods. AAPS PharmSciTech 5(4), e67
Martinac A, Filipovic-Grcic J, Voinovich D, Perissutti B, Franceschinis E (2005) Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 291:69–77
Meckelein B, Externest D, Schmidt MA, Frey A (2003) Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures. Clin Diagn Lab Immunol 10:831–834
Sonia TA, Sharma CP (2011) Chitosan and its derivatives for drug delivery perspective. Adv Polym Sci 243:23–53
Rinaudo M (2006) Chitin and chitosan: properties and applications. Prog Polym Sci 31:603–632
Dutta PK, Dutta J, Tripathi VS (2004) Chitin and chitosan: chemistry, properties and applications. J Sci Ind Res 63:20–31
Jesus S, Borchard G, Borges O (2013) Freeze dried chitosan/poly-e-caprolactone and poly-e-caprolactone nanoparticles: evaluation of their potential as DNA and antigen delivery systems. J Genet Syndr Gene Ther 4:164
Pillai CKS, Paul W, Sharma CP (2009) Chitin and chitosan polymers: chemistry, solubility and fiber formation. Prog Polym Sci 34:641–678
Jiang J, Oberdörster G, Biswas P (2009) Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanoparticle Res 11:77–89
Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A (2004) Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 278:1–23
Labet M, Thielemans W (2009) Synthesis of polycaprolactone: a review. Chem Soc Rev 38:3484–3504
Koppolu BP et al (2014) Controlling chitosan-based encapsulation for protein and vaccine delivery. Biomaterials 35:4382–4389
Chuah LH, Billa N, Roberts CJ, Burley JC, Manickam S (2013) Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon. Pharm Dev Technol 18:591–599
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Jesus, S., Soares, E., Borges, O. (2016). Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal Vaccination. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 1404. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-3389-1_45
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3389-1_45
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-3388-4
Online ISBN: 978-1-4939-3389-1
eBook Packages: Springer Protocols